NEW YORK, Feb 20 (Reuters) - Veradigm ( MDRX ) will add

four new directors to its board in an agreement with investor

Kent Lake Capital, the healthcare technology company said on

Thursday just weeks after concluding a strategic review.

Healthcare industry executives Vinit Asar and Louis

Silverman joined the board on Thursday and two additional

independent directors, who will be selected with Kent Lake's

approval, will join later, the company said.

Board member Jonathan Judge stepped down and Chairman Greg

Garrison will retire soon. The board currently has five members.

Earlier this year Veradigm ( MDRX ), which changed its name from

Allscripts two years ago, said it will continue to be a

"standalone" company after having reviewed strategic

alternatives, including a potential sale.

Kent Lake managing member Benjamin Natter said he believes

the company, currently valued at $527 million, can deliver value

to customers and generate attractive returns for shareholders.

Veradigm ( MDRX ) provides physician practices, hospitals, and other

healthcare providers with practice management and electronic

health record technology as well as financial and analytics

technology.